Trials / Conditions / Recurrent or Metastatic Solid Tumors
Recurrent or Metastatic Solid Tumors
5 registered clinical trials studyying Recurrent or Metastatic Solid Tumors — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors NCT07015697 | Daiichi Sankyo | Phase 1 |
| Active Not Recruiting | A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors NCT07387874 | Lixiaoling | — |
| Recruiting | A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Met NCT06330064 | Daiichi Sankyo | Phase 2 |
| Not Yet Recruiting | An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases NCT06093698 | ITabMed Co., Ltd. | Phase 1 |
| Completed | A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Adva NCT02221960 | MedImmune LLC | Phase 1 |